484 related articles for article (PubMed ID: 21894214)
1. Antiresorptive therapies for osteoporosis: a clinical overview.
Chen JS; Sambrook PN
Nat Rev Endocrinol; 2011 Sep; 8(2):81-91. PubMed ID: 21894214
[TBL] [Abstract][Full Text] [Related]
2. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
Reginster JY
Drugs; 2011 Jan; 71(1):65-78. PubMed ID: 21175240
[TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
4. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
[TBL] [Abstract][Full Text] [Related]
5. [[Antiresorptive agents in the treatment of osteoporosis].
Novak S
Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Lewiecki EM
J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
[TBL] [Abstract][Full Text] [Related]
7. Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosis.
Reginster JY; Neuprez A; Beaudart C; Lecart MP; Sarlet N; Bernard D; Disteche S; Bruyere O
Drugs Aging; 2014 Jun; 31(6):413-24. PubMed ID: 24797286
[TBL] [Abstract][Full Text] [Related]
8. Individualizing osteoporosis therapy.
Silverman S; Christiansen C
Osteoporos Int; 2012 Mar; 23(3):797-809. PubMed ID: 22218417
[TBL] [Abstract][Full Text] [Related]
9. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.
Murad MH; Drake MT; Mullan RJ; Mauck KF; Stuart LM; Lane MA; Abu Elnour NO; Erwin PJ; Hazem A; Puhan MA; Li T; Montori VM
J Clin Endocrinol Metab; 2012 Jun; 97(6):1871-80. PubMed ID: 22466336
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
Ishtiaq S; Fogelman I; Hampson G
J Endocrinol Invest; 2015 Jan; 38(1):13-29. PubMed ID: 25194424
[TBL] [Abstract][Full Text] [Related]
11. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
12. The effect of antiresorptives on bone quality.
Recker RR; Armas L
Clin Orthop Relat Res; 2011 Aug; 469(8):2207-14. PubMed ID: 21562893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.
Valverde P
Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Meier C; Uebelhart B; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Frey D; Kressig RW; Lamy O; Lippuner K; Stute P; Suhm N; Ferrari S
Swiss Med Wkly; 2017; 147():w14484. PubMed ID: 28871570
[TBL] [Abstract][Full Text] [Related]
15. Treating osteoporosis to prevent fractures: current concepts and future developments.
Lorentzon M
J Intern Med; 2019 Apr; 285(4):381-394. PubMed ID: 30657216
[TBL] [Abstract][Full Text] [Related]
16. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
17. Data from extension trials: denosumab and zoledronic acid.
Dore RK
Curr Osteoporos Rep; 2012 Mar; 10(1):16-21. PubMed ID: 22086442
[TBL] [Abstract][Full Text] [Related]
18. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.
Tarantino U; Celi M; Feola M; Liuni FM; Resmini G; Iolascon G
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S65-9. PubMed ID: 24046047
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological management of osteogenesis.
Nardone V; D'Asta F; Brandi ML
Clinics (Sao Paulo); 2014 Jun; 69(6):438-46. PubMed ID: 24964310
[TBL] [Abstract][Full Text] [Related]
20. Developments in the pharmacotherapeutic management of osteoporosis.
Close P; Neuprez A; Reginster JY
Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
